| Parameter | Number (%) |
| Site |
|
| Nasopharynx | 11 (28.2%) |
| Oropharynx | 4 (10.3%) |
| Hypopharynx | 1 (2.6%) |
| Supraglottic larynx | 1 (2.6%) |
| Glottic larynx | 4 (10.3%) |
| Postcricoid | 6 (15.4%) |
| Mandible | 5 (12.8%) |
| Maxilla | 3 (7.7%) |
| Tongue | 3 (7.7%) |
| Sino-nasal | 1 (2.6%) |
| Pathological type |
|
| Squamous cell carcinoma | 23 (58.9%) |
| Adenocarcinoma | 14 (35.9%) |
| Mucoepidermoid | 1 (2.6%) |
| Adenomucinous | 1 (2.6%) |
| Grade |
|
| I | 4 (10.3%) |
| II | 18 (46.2%) |
| III | 7 (17.9%) |
| IV | 10 (25.6%) |
| T-stage |
|
| T1 | 2 (5.1%) |
| T2 | 10 (25.6%) |
| T3 | 14 (35.9%) |
| T4a | 9 (23.1%) |
| T4b | 4 (10.3%) |
| N-stage |
|
| N0 | 11 (28.2%) |
| N1 | 8 (20.6%) |
| N2 | 10 (25.6%) |
| N3 | 10 (25.6%) |
| TNM stage |
|
| III | 5 (12.8%) |
| IVA | 19 (48.7%) |
| IVB | 15 (38.5%) |